Two Sigma Investments’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$655K Buy
124,674
+43,937
+54% +$273K ﹤0.01% 3871
2026
Q2
$499K Buy
+80,737
New +$443K ﹤0.01% 4162
2024
Q1
– Sell
-56,948
Closed -$285K – 2989
2023
Q4
$285K Buy
+56,948
New +$251K ﹤0.01% 2712
2020
Q3
– Sell
-3,506
Closed -$255K – 3017
2020
Q2
$255K Buy
3,506
+3,051
+671% +$211K ﹤0.01% 2483
2020
Q1
$24K Buy
+455
New +$30.4K ﹤0.01% 2966
2019
Q4
– Sell
-5,196
Closed -$294K – 3597
2019
Q3
$294K Sell
5,196
-67
-1% -$5.02K ﹤0.01% 2978
2019
Q2
$629K Buy
+5,263
New +$882K ﹤0.01% 2320

Other funds holding ABEO

Two Sigma Investments's ABEO Position: Q3 2026 in Review

Two Sigma Investments increased its Abeona Therapeutics (ABEO) stake by 54% in Q3 2026, buying an estimated $273K and bringing the position to 124,674 shares worth $655K. The position accounts for ﹤0.01% of the portfolio, ranked #3871.

Two Sigma Investments first reported a position in ABEO in Q2 2019 and has held it in 7 quarters since. 115 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

  • Two Sigma Investments held 124,674 shares of Abeona Therapeutics worth $655K as of Q3 2026.
  • Two Sigma Investments bought 43,937 Abeona Therapeutics shares in Q3 2026, an estimated $273K.
  • Abeona Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #3871 holding.
  • Two Sigma Investments first reported a position in Abeona Therapeutics in Q2 2019 and has held it in 7 quarters since.
  • 115 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.